Publicacions en què col·labora amb JAVIER RODRIGUEZ CARRIO (23)

2023

  1. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages

    Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907

2021

  1. HLA–B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti–Carbamylated Protein Antibody–Positive/Anti–Cyclic Citrullinated Peptide–Negative Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 963-969

  2. Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 73, Núm. 3, pp. 401-413

2020

  1. Glyca levels during the earliest stages of rheumatoid arthritis: Potential use as a biomarker of subclinical cardiovascular disease

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-19

2019

  1. IRF4 and IRGS delineate clinically relevant gene expression signatures in systemic lupus erythematosus and rheumatoid arthritis

    Frontiers in Immunology, Vol. 10, Núm. JAN

  2. Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study

    Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360

  3. Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Heterogeneity of the type I interferon signature in rheumatoid arthritis: A potential limitation for its use as a clinical biomarker

    Frontiers in Immunology, Vol. 8, Núm. JAN

  2. Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment Outcomes

    Frontiers in immunology, Vol. 9, pp. 2351

2017

  1. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein

    Journal of Clinical Lipidology, Vol. 11, Núm. 4, pp. 1043-1054.e2

2016

  1. Antibodies to paraoxonase 1 are associated with oxidant status and endothelial activation in rheumatoid arthritis

    Clinical Science, Vol. 130, Núm. 21, pp. 1889-1899

  2. Non-esterified fatty acids profiling in rheumatoid arthritis: Associations with clinical features and Th1 response

    PLoS ONE, Vol. 11, Núm. 8

  3. Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti-High-Density Lipoprotein Antibodies in Patients with Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease

    Arthritis and Rheumatology, Vol. 68, Núm. 6, pp. 1367-1376

2015

  1. Altered profile of circulating microparticles in rheumatoid arthritis patients

    Clinical Science, Vol. 128, Núm. 7, pp. 437-448

  2. Angiogenic T cells are decreased in rheumatoid arthritis patients

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 5, pp. 921-927

  3. Antibodies to high-density lipoproteins are associated with inflammation and cardiovascular disease in rheumatoid arthritis patients

    Translational Research, Vol. 166, Núm. 6, pp. 529-539

  4. Good response to tumour necrosis factor alpha blockade results in an angiogenic T cell recovery in rheumatoid arthritis patients

    Rheumatology (United Kingdom)

  5. Red cell distribution width is associated with endothelial progenitor cell depletion and vascular-related mediators in rheumatoid arthritis

    Atherosclerosis, Vol. 240, Núm. 1, pp. 131-136

  6. TNFα polymorphism as marker of immunosenescence for rheumatoid arthritis patients

    Experimental Gerontology, Vol. 61, pp. 123-129

2014

  1. IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients

    PLoS ONE, Vol. 9, Núm. 1